Treating Refractory Generalized Epilepsy with Stimulation
نویسندگان
چکیده
منابع مشابه
Treating refractory generalized epilepsy with stimulation.
Commentary Idiopathic generalized epilepsies (IGE) represent around 20% of all new-onset epilepsy and are controlled with various an-tiepileptic drugs in up to 80% of the cases. For the remaining 20% with intractable IGE, treatment options are limited. Most new AED clinical trials evaluate cohorts with partial epilepsy. The ketogenic diet has helped many children with catastrophic symptomatic g...
متن کاملTreating refractory epilepsy with tiagabine: clinical experience
Epilepsy remains difficult to treat with more than 30% of patients being refractory to conventional anticonvulsant therapy. Combination therapy may improve seizure control in some of these patients. Tiagabine is a new anticonvulsant that has a unique mechanism of action as a selective gamma-aminobutyric acid (GABA) re-uptake inhibitor (SGRI). Twenty consecutive patients with refractory epilepsy...
متن کاملTreating refractory epilepsy in adults.
http://bmj.com/cgi/content/full/332/7541/562 Updated information and services can be found at: These include: References http://bmj.com/cgi/content/full/332/7541/562#BIBL This article cites 10 articles, 6 of which can be accessed free at: Rapid responses http://bmj.com/cgi/eletter-submit/332/7541/562 You can respond to this article at: http://bmj.com/cgi/content/full/332/7541/562#responses free...
متن کاملDeep brain stimulation for refractory epilepsy
Deep brain stimulation (DBS) is a method of treatment utilized to control medically refractory epilepsy (RE). Patients with medically refractory epilepsy who do not achieve satisfactory control of seizures with pharmacological treatment or surgical resection of the epileptic focus and those who do not qualify for surgery could benefit from DBS. The most frequently used stereotactic targets for ...
متن کاملVagus nerve stimulation for refractory epilepsy
Vagus nerve stimulation (VNS) is a neurophysiological treatment for patients with medically or surgically refractory epilepsy. Since the first human implant in 1989, more than 10 000 patients have been treated with VNS. Two randomized controlled studies have shown a statistically significant decrease in seizure frequency during a 12-week treatment period versus a baseline period when 'high stim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Epilepsy Currents
سال: 2014
ISSN: 1535-7597,1535-7511
DOI: 10.5698/1535-7597-14.2.76